Patients presenting for a scheduled cesarean delivery who require a neuraxial anesthetic will be randomized to receive intravenous remimazolam or dexmedetomidine for procedural sedation during the placement of their spinal or epidural anesthesia.
Inclusion Criteria
- Pregnant patient scheduled for cesarean delivery
- ≥ 18 years old
- ≥ 37 weeks gestational age
Exclusion Criteria
- Pregnant patients \< 18 years old
- Pregnant patients \< 37 weeks gestational age
- Has known hypersensitivity to benzodiazepines or dexmedetomidine
- Has history of chronic benzodiazepine use or misuse